NCT00820651 Efficacy and Safety of Diamel in Patients With Nonalcoholic Steatohepatitis Status COMPLETED Phase PHASE3
NCT00794716 PK of NRL972 in Patients with Nonalcoholic Steatohepatitis (NASH) and Non-Alcoholic Fatty Liver Disease (NAFLD) Status COMPLETED Phase PHASE2
NCT00740610 Safety, Tolerability, Pharmacokinetics and Activity of GS-9450 in Adults With Non-Alcoholic Steatohepatitis (NASH) Status COMPLETED Phase PHASE2
NCT00699036 Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Avandia in the Treatment of Nonalcoholic Steatohepatitis (NASH) Status UNKNOWN Phase PHASE2
NCT00590161 Pentoxifylline in Patients With Nonalcoholic Steatohepatitis Status COMPLETED Phase PHASE2
NCT00586885 Effects of Alanine in Patients With Nonalcoholic Steatohepatitis Status COMPLETED Phase NA
NCT00586313 Endoscopic Ultrasound(EUS)-Guided TRUCUT Biopsy (EUS-TCB) of Suspected Nonalcoholic Fatty Liver Disease(NAFLD.) Status COMPLETED Phase NA
NCT00509418 Efficacy and Safety of Viusid in Patients With Nonalcoholic Steatohepatitis Status COMPLETED Phase PHASE3
NCT00267670 Pentoxifylline/Nonalcoholic Steatohepatitis (NASH) Study: The Effect of Pentoxifylline on NASH Status COMPLETED Phase PHASE2/PHASE3
NCT00227110 Role of Pioglitazone in the Treatment of Non-alcoholic Steatohepatitis (NASH) Status COMPLETED Phase PHASE4
NCT00152711 Impact of nCPAP Treatment on Liver Function in Patients With Sleep Apnea Syndrome and Nonalcoholic Steatohepatitis Status UNKNOWN Phase NA
NCT00013598 Treatment of Nonalcoholic Steatohepatitis With Pioglitazone Status COMPLETED Phase PHASE2